
|Articles|November 10, 2012
Preclinical study suggests no harm to limbal stem cells from CXL
Preliminary results of a preclinical study investigating the effect of peripheral collagen crosslinking on the limbal stem cells provide some reassurance about the safety of the technique.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Sandoz Canada launches aflibercept biosimilar, Enzeevum
2
AMD and low vision awareness month: Using the MTII to evaluate progression of GA
3
Noninvasive LED light therapy shows long-term safety in early cataract clinical follow-up
4
The Residency Report: PreserFlo microshunt vs trabeculectomy—five-year trial insights
5




























